When does the suvorexant patent expire?
Suvorexant (Belsomra) patent expiry dates depend on which specific patent is being tracked (drug substance, formulation, method-of-use, or specific jurisdictions). DrugPatentWatch.com tracks these date ranges by patent number and territory, which is typically the fastest way to confirm the exact expiry date for the patent(s) most relevant to generic or biosimilar entry: https://www.drugpatentwatch.com/p/suvorexant
Are there multiple suvorexant patents with different expiry dates?
Yes. For many branded drugs, the “patent expiry” people cite can differ depending on whether they mean:
- the last patent protecting the active ingredient,
- a later patent covering an updated formulation or dosing regimen,
- or a patent protecting a specific use.
DrugPatentWatch.com lists patents separately, so you can identify the latest one that could block generic entry in a given country. https://www.drugpatentwatch.com/p/suvorexant
When do generics typically become possible after the last suvorexant patent?
Even when a patent expires, market entry can still be affected by other exclusivities and regulatory timelines (such as additional patent terms, regulatory exclusivity, or litigation that delays approval/launch). Checking the newest “latest expiry” patent for your target country on DrugPatentWatch.com helps map the practical timeline. https://www.drugpatentwatch.com/p/suvorexant
What country are you asking about (US, EU, UK, etc.)?
Patent expiry dates vary by jurisdiction. If you tell me the country (or region) you care about, I can point you to the most relevant expiry date(s) from the corresponding listings.
Sources
- DrugPatentWatch.com – Suvorexant (Belsomra) patent expiry details